How Researchers Define Vulnerable Populations in HIV/AIDS Clinical Trials

AIDS and Behavior - Netherlands
doi 10.1007/s10461-010-9785-x
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Development of Diagnostic Criteria for Serious Non-Aids Events in HIV Clinical Trials

HIV Clinical Trials
2010English

Cancer Researchers Push to Relax Rules for Clinical Trials

Nature
Multidisciplinary
2018English

How Does HIV?AIDS Surveillance Work in NSW?

New South Wales Public Health Bulletin
1999English

Boceprevir and Antiretroviral Pharmacokinetic Interactions in HIV/HCV Co-Infected Persons: AIDS Clinical Trials Group Study A5309s

Drugs in R and D
Pharmacology
2017English

Protecting Vulnerable Populations

BMJ
2007English

Evaluation of Change in CD4+ Cell Counts in AIDS Clinical Trials

Statistical Methods in Medical Research
Health Information ManagementEpidemiologyStatisticsProbability
2007English

Smoking Among Vulnerable Populations in Serbia

Tobacco Prevention & Cessation
2017English

Clinical Effectiveness of Dolutegravir in the Treatment of HIV/AIDS

Infection and Drug Resistance
Infectious DiseasesPharmacology
2015English

Researchers, Regulators, and Sponsors Views on Pediatric Clinical Trials: A Multinational Study

Pediatrics
Child HealthPediatricsPerinatology
2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy